Holen Sie sich die Stockscreener-App
1.03
0.96%
-0.01
Handel nachbörslich:
1.06
0.03
+2.91%
Schlusskurs vom Vortag:
$1.04
Offen:
$1.03
24-Stunden-Volumen:
220.02K
Relative Volume:
0.08
Marktkapitalisierung:
$11.09M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-11.66M
KGV:
-0.1263
EPS:
-8.156
Netto-Cashflow:
$-11.09M
1W Leistung:
-4.63%
1M Leistung:
-4.63%
6M Leistung:
-62.41%
1J Leistung:
-49.01%
1-Tages-Spanne:
$1.01
$1.06
1-Wochen-Bereich:
$1.01
$1.10
52-Wochen-Spanne:
$0.9657
$4.1899
Phio Pharmaceuticals Corp Stock (PHIO) Company Profile
Firmenname
Phio Pharmaceuticals Corp
Sektor
Branche
Telefon
(508) 767-3861
Adresse
411 SWEDELAND ROAD, KING OF PRUSSIA, MA
Vergleichen Sie PHIO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PHIO
Phio Pharmaceuticals Corp
|
1.03 | 11.20M | 0 | -11.66M | -11.09M | -8.156 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.17 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.25 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
864.42 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
354.75 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
336.16 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Phio Pharmaceuticals Corp Stock (PHIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-05 | Fortgesetzt | H.C. Wainwright | Buy |
| 2020-08-05 | Eingeleitet | H.C. Wainwright | Buy |
Phio Pharmaceuticals Corp Aktie (PHIO) Neueste Nachrichten
Phio Pharmaceuticals Announces Participation in Third Annual DealFlow Discovery Conference - TMX Newsfile
Cancer drug developer Phio joins free Atlantic City investor discovery event - Stock Titan
Aug PreEarnings: Is Hennessy Capital Investment Corp VII stock a top performer YTDJuly 2025 Macro Moves & Consistent Return Investment Signals - baoquankhu1.vn
Phio Reports Positive Phase 1b PH-762 Skin Cancer Data - TipRanks
Phio Pharmaceuticals Corp Announces Key Tumor Response Data from PH-762 Trial - TradingView
Phio Pharmaceuticals reports 70% response rate in skin cancer trial - Investing.com
Phio Pharmaceuticals Announces Key Tumor Response Data from all Cohorts in Intratumoral PH-762 Dose Escalation Cutaneous Carcinoma Trial - TMX Newsfile
Is Phio Pharmaceuticals Corp. stock a contrarian buyLong-Term Growth Stocks & Low Risk Trading Plans - bollywoodhelpline.com
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Virtual Non-Deal Roadshow Series - TMX Newsfile
Retail Trends: Does Phio Pharmaceuticals Corp offer margin of safetyJuly 2025 Review & Community Trade Idea Sharing Platform - baoquankhu1.vn
Phio Pharmaceuticals Announces Participation in the Sidoti Micro-Cap Virtual Investor Conference January 21-22, 2026 - TMX Newsfile
Cancer gene-silencing update from Phio at Sidoti virtual conference - Stock Titan
Pullback Watch: How does Phoenix Laser Systems Inc Preferred Security score in quality rankingsBreakout Watch & Fast Gain Swing Alerts - baoquankhu1.vn
Guidance Update: What is the next catalyst for Phio Pharmaceuticals Corp2025 Investor Takeaways & Expert Curated Trade Setups - baoquankhu1.vn
Aug Big Picture: Can Phio Pharmaceuticals Corp stock rebound after recent weaknessWeekly Volume Report & Trade Opportunity Analysis - Bộ Nội Vụ
Market Overview: Is Phio Pharmaceuticals Corp a stock for growth or value investorsMarket Sentiment Review & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
Trend Recap: How Phio Pharmaceuticals Corp stock reacts to Fed rate cutsQuarterly Performance Summary & High Win Rate Trade Tips - Bộ Nội Vụ
Why Phio Pharmaceuticals Corp. stock is a value investor pickShort Setup & Free Weekly Chart Analysis and Trade Guides - Улправда
Will Phio Pharmaceuticals Corp. stock benefit from infrastructure spendingJuly 2025 Setups & Safe Entry Trade Signal Reports - Улправда
Why retail investors pile into Phio Pharmaceuticals Corp. stock2026 world cup usa national team semifinals defensive leaders low block defense odds analysis insights - Улправда
Insider Buying: Robert Bitterman Acquires Additional Shares of P - GuruFocus
PHIO News Today | Why did Phio Pharmaceuticals stock go up today? - MarketBeat
Phio Pharmaceuticals Corp. (PHIO) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Momentum Shift: Can Phio Pharmaceuticals Corp stock beat analyst upgradesBuy Signal & Reliable Breakout Forecasts - moha.gov.vn
Best Value Stocks to Buy for April 23rd - MSN
Phio Pharma Stock Quadruples On Positive Data From Cancer Treatment Trial: Retail’s Elated - MSN
Phio Pharmaceuticals chairman Bitterman buys $5,100 in stock By Investing.com - Investing.com South Africa
Phio Pharmaceuticals chairman Bitterman buys $5,100 in stock - Investing.com
Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-deal Roadshow Series - TMX Newsfile
MSN Money - MSN
Phio Pharmaceuticals Announces Upcoming Presentation at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) - TMX Newsfile
Phio To Commence A Toxicology Study For PH-762; Initiatives Underway For A Viable Product In 2026 - Nasdaq
Phio to begin FDA-required toxicology study for cancer drug PH-762 - Investing.com Nigeria
Phio Advances PH-762 With FDA-Backed Toxicology Study - TipRanks
Phio to begin FDA-required toxicology study for cancer drug PH-762 By Investing.com - Investing.com South Africa
Phio Pharmaceuticals Corp to begin toxicology study for PH-762 before human trialsSEC filing - marketscreener.com
Phio Pharmaceuticals (NASDAQ: PHIO) details FDA-cleared PH-762 tox study plan - Stock Titan
Phio Pharmaceuticals Corp Advances PH-762 Drug Development - TradingView — Track All Markets
Phio Pharmaceuticals Announces Significant Step Forward in its Drug Development Program for PH-762 - TMX Newsfile
Risk Off: Why Phio Pharmaceuticals Corp. stock appeals to dividend seekersJuly 2025 Decliners & Growth Focused Stock Pick Reports - Улправда
How Phio Pharmaceuticals Corp. stock benefits from strong dollarDip Buying & Detailed Earnings Play Alerts - Улправда
How Phio Pharmaceuticals Corp. stock responds to policy changesWeekly Trend Recap & Reliable Intraday Trade Alerts - Улправда
Can Phio Pharmaceuticals Corp. (44R1) stock sustain breakout momentum - DonanımHaber
How Phio Pharmaceuticals Corp. stock reacts to Fed rate cutsJuly 2025 Macro Moves & Weekly Setup with ROI Potential - DonanımHaber
Why Phio Pharmaceuticals Corp. stock appeals to dividend seekersQuarterly Trade Review & Risk Managed Investment Strategies - Улправда
How resilient is Phio Pharmaceuticals Corp. stock in market downturns2025 Market Sentiment & Weekly High Momentum Picks - Улправда
New Strong Buy Stocks for May 28th - MSN
We Asked Retail What's Next For Phio Pharma After Monday's Blistering Rally: Most See More Room To Run - MSN
EBIT per share of Phio Pharmaceuticals Corp. – BER:44R1 - TradingView
Will Phio Pharmaceuticals Corp. (44R1) stock beat revenue estimatesMarket Performance Summary & Risk Managed Trade Strategies - Newser
How Phio Pharmaceuticals Corp. (44R1) stock reacts to fiscal policiesJuly 2025 Update & AI Optimized Trading Strategy Guides - Newser
Finanzdaten der Phio Pharmaceuticals Corp-Aktie (PHIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.09%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):